APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medical Toxicology Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Medical Toxicology Service Market Outlook and Growth Opportunities 2026

4 January 2026193 pages

Choose your research edition.

Industry ResearchMedical Toxicology Service Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Toxicology Service Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Medical Toxicology Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Toxicology Service Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Toxicology Service Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Medical Toxicology Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Medical Toxicology Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Medical Toxicology Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medical Toxicology Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Medical Toxicology Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Medical Toxicology Service market include Charles River, Labcorp, Envigo, MPI Research, Eurofins, Wuxi Apptec, SGS, Merck and Evotec, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Medical Toxicology Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Medical Toxicology Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Medical Toxicology Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Medical Toxicology Service market.

Medical Toxicology Service Segment by Company

Charles River

Labcorp

Envigo

MPI Research

Eurofins

Wuxi Apptec

SGS

Merck

Evotec

Bureau Veritas

Medical Toxicology Service Segment by Type

Systemic Toxicology

Developmental & Reproductive Toxicology

Medical Toxicology Service Segment by Application

Pharmaceutical

Medical Devices

Cosmetic

Chemical

Medical Toxicology Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Medical Toxicology Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Medical Toxicology Service key companies, revenue, market share, and recent developments.

3. To split the Medical Toxicology Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Medical Toxicology Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Medical Toxicology Service significant trends, drivers, influence factors in global and regions.

6. To analyze Medical Toxicology Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Toxicology Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Toxicology Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Toxicology Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Toxicology Service industry.

Chapter 3: Detailed analysis of Medical Toxicology Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Medical Toxicology Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Medical Toxicology Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Medical Toxicology Service Industry Trends Table 2. Medical Toxicology Service Industry Drivers Table 3. Medical Toxicology Service Industry Opportunities and Challenges Table 4. Medical Toxicology Service Industry Restraints Table 5. Global Medical Toxicology Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Medical Toxicology Service Revenue Share by Company (2021-2026) Table 7. Global Medical Toxicology Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Medical Toxicology Service Key Company Manufacturing Base & Headquarters Table 9. Global Medical Toxicology Service Company, Product Type & Application Table 10. Global Medical Toxicology Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Medical Toxicology Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Systemic Toxicology Table 15. Significant Companies of Developmental & Reproductive Toxicology Table 16. Global Medical Toxicology Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Medical Toxicology Service Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Medical Toxicology Service Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Medical Toxicology Service Sales Value Share by Type (2021-2026) Table 20. Global Medical Toxicology Service Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Pharmaceutical Table 22. Significant Companies of Medical Devices Table 23. Significant Companies of Cosmetic Table 24. Significant Companies of Chemical Table 25. Global Medical Toxicology Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Medical Toxicology Service Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Medical Toxicology Service Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Medical Toxicology Service Sales Value Share by Application (2021-2026) Table 29. Global Medical Toxicology Service Sales Value Share by Application (2027-2032) Table 30. Global Medical Toxicology Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Medical Toxicology Service Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Medical Toxicology Service Sales Value Share by Region (2021-2026) Table 33. Global Medical Toxicology Service Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Medical Toxicology Service Sales Value Share by Region (2027-2032) Table 35. Global Medical Toxicology Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Medical Toxicology Service Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Medical Toxicology Service Sales Value Market Share by Country (2021-2026) Table 38. Global Medical Toxicology Service Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Medical Toxicology Service Sales Value Market Share by Country (2027-2032) Table 40. Charles River Company Information Table 41. Charles River Business Overview Table 42. Charles River Medical Toxicology Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Charles River Medical Toxicology Service Product Portfolio Table 44. Charles River Recent Development Table 45. Labcorp Company Information Table 46. Labcorp Business Overview Table 47. Labcorp Medical Toxicology Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Labcorp Medical Toxicology Service Product Portfolio Table 49. Labcorp Recent Development Table 50. Envigo Company Information Table 51. Envigo Business Overview Table 52. Envigo Medical Toxicology Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Envigo Medical Toxicology Service Product Portfolio Table 54. Envigo Recent Development Table 55. MPI Research Company Information Table 56. MPI Research Business Overview Table 57. MPI Research Medical Toxicology Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. MPI Research Medical Toxicology Service Product Portfolio Table 59. MPI Research Recent Development Table 60. Eurofins Company Information Table 61. Eurofins Business Overview Table 62. Eurofins Medical Toxicology Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Eurofins Medical Toxicology Service Product Portfolio Table 64. Eurofins Recent Development Table 65. Wuxi Apptec Company Information Table 66. Wuxi Apptec Business Overview Table 67. Wuxi Apptec Medical Toxicology Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Wuxi Apptec Medical Toxicology Service Product Portfolio Table 69. Wuxi Apptec Recent Development Table 70. SGS Company Information Table 71. SGS Business Overview Table 72. SGS Medical Toxicology Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. SGS Medical Toxicology Service Product Portfolio Table 74. SGS Recent Development Table 75. Merck Company Information Table 76. Merck Business Overview Table 77. Merck Medical Toxicology Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Merck Medical Toxicology Service Product Portfolio Table 79. Merck Recent Development Table 80. Evotec Company Information Table 81. Evotec Business Overview Table 82. Evotec Medical Toxicology Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Evotec Medical Toxicology Service Product Portfolio Table 84. Evotec Recent Development Table 85. Bureau Veritas Company Information Table 86. Bureau Veritas Business Overview Table 87. Bureau Veritas Medical Toxicology Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Bureau Veritas Medical Toxicology Service Product Portfolio Table 89. Bureau Veritas Recent Development Table 90. Research Programs/Design for This Report Table 91. Authors List of This Report Table 92. Secondary Sources Table 93. Primary Sources List of Figures Figure 1. Medical Toxicology Service Product Image Figure 2. Global Medical Toxicology Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Toxicology Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Medical Toxicology Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Systemic Toxicology Image Figure 8. Developmental & Reproductive Toxicology Image Figure 9. Global Medical Toxicology Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Medical Toxicology Service Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Medical Toxicology Service Sales Value Share by Type (2021-2032) Figure 12. Pharmaceutical Image Figure 13. Medical Devices Image Figure 14. Cosmetic Image Figure 15. Chemical Image Figure 16. Global Medical Toxicology Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Medical Toxicology Service Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Medical Toxicology Service Sales Value Share by Application (2021-2032) Figure 19. Global Medical Toxicology Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Medical Toxicology Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Medical Toxicology Service Sales Value (2021-2032) & (US$ Million) Figure 22. North America Medical Toxicology Service Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Medical Toxicology Service Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Medical Toxicology Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Medical Toxicology Service Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Medical Toxicology Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Medical Toxicology Service Sales Value (2021-2032) & (US$ Million) Figure 28. South America Medical Toxicology Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Medical Toxicology Service Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Medical Toxicology Service Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Medical Toxicology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Medical Toxicology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Medical Toxicology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Medical Toxicology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Medical Toxicology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Medical Toxicology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Medical Toxicology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Medical Toxicology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Medical Toxicology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Medical Toxicology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Medical Toxicology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Medical Toxicology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Medical Toxicology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Medical Toxicology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Medical Toxicology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Medical Toxicology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Medical Toxicology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Medical Toxicology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Medical Toxicology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Medical Toxicology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Medical Toxicology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Medical Toxicology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Medical Toxicology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Medical Toxicology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Medical Toxicology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Medical Toxicology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Medical Toxicology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Medical Toxicology Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Systemic Toxicology
  • Developmental & Reproductive Toxicology
Applications
  • Pharmaceutical
  • Medical Devices
  • Cosmetic
  • Chemical
Companies covered
  • Charles River
  • Labcorp
  • Envigo
  • MPI Research
  • Eurofins
  • Wuxi Apptec
  • SGS
  • Merck
  • Evotec
  • Bureau Veritas

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Medical Toxicology Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Medical Toxicology Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Medical Toxicology Service Market Dynamics
  1. 2.1 Medical Toxicology Service Industry Trends
  2. 2.2 Medical Toxicology Service Industry Drivers
  3. 2.3 Medical Toxicology Service Industry Opportunities and Challenges
  4. 2.4 Medical Toxicology Service Industry Restraints
3 Medical Toxicology Service Market by Company
  1. 3.1 Global Medical Toxicology Service Company Revenue Ranking in 2025
  2. 3.2 Global Medical Toxicology Service Revenue by Company (2021-2026)
  3. 3.3 Global Medical Toxicology Service Company Ranking (2024-2026)
  4. 3.4 Global Medical Toxicology Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Medical Toxicology Service Company Product Type and Application
  6. 3.6 Global Medical Toxicology Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Medical Toxicology Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Medical Toxicology Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Medical Toxicology Service Market by Type
  1. 4.1 Medical Toxicology Service Type Introduction
  2. 4.1.1 Systemic Toxicology
  3. 4.1.2 Developmental & Reproductive Toxicology
  4. 4.2 Global Medical Toxicology Service Sales Value by Type
  5. 4.2.1 Global Medical Toxicology Service Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Medical Toxicology Service Sales Value by Type (2021-2032)
  7. 4.2.3 Global Medical Toxicology Service Sales Value Share by Type (2021-2032)
5 Medical Toxicology Service Market by Application
  1. 5.1 Medical Toxicology Service Application Introduction
  2. 5.1.1 Pharmaceutical
  3. 5.1.2 Medical Devices
  4. 5.1.3 Cosmetic
  5. 5.1.4 Chemical
  6. 5.2 Global Medical Toxicology Service Sales Value by Application
  7. 5.2.1 Global Medical Toxicology Service Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Medical Toxicology Service Sales Value by Application (2021-2032)
  9. 5.2.3 Global Medical Toxicology Service Sales Value Share by Application (2021-2032)
6 Medical Toxicology Service Regional Value Analysis
  1. 6.1 Global Medical Toxicology Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Medical Toxicology Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Medical Toxicology Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Medical Toxicology Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Medical Toxicology Service Sales Value (2021-2032)
  7. 6.3.2 North America Medical Toxicology Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Medical Toxicology Service Sales Value (2021-2032)
  10. 6.4.2 Europe Medical Toxicology Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Medical Toxicology Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Medical Toxicology Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Medical Toxicology Service Sales Value (2021-2032)
  16. 6.6.2 South America Medical Toxicology Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Medical Toxicology Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Medical Toxicology Service Sales Value Share by Country, 2025 VS 2032
7 Medical Toxicology Service Country-level Value Analysis
  1. 7.1 Global Medical Toxicology Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Medical Toxicology Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Medical Toxicology Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Medical Toxicology Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Medical Toxicology Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Medical Toxicology Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Medical Toxicology Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Medical Toxicology Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Medical Toxicology Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Medical Toxicology Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Medical Toxicology Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Medical Toxicology Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Medical Toxicology Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Medical Toxicology Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Medical Toxicology Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Medical Toxicology Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Medical Toxicology Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Medical Toxicology Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Medical Toxicology Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Medical Toxicology Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Medical Toxicology Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Medical Toxicology Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Medical Toxicology Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Medical Toxicology Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Medical Toxicology Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Medical Toxicology Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Medical Toxicology Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Medical Toxicology Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Medical Toxicology Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Medical Toxicology Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Medical Toxicology Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Medical Toxicology Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Medical Toxicology Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Medical Toxicology Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Charles River
  2. 8.1.1 Charles River Company Information
  3. 8.1.2 Charles River Business Overview
  4. 8.1.3 Charles River Medical Toxicology Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Charles River Medical Toxicology Service Product Portfolio
  6. 8.1.5 Charles River Recent Developments
  7. 8.2 Labcorp
  8. 8.2.1 Labcorp Company Information
  9. 8.2.2 Labcorp Business Overview
  10. 8.2.3 Labcorp Medical Toxicology Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Labcorp Medical Toxicology Service Product Portfolio
  12. 8.2.5 Labcorp Recent Developments
  13. 8.3 Envigo
  14. 8.3.1 Envigo Company Information
  15. 8.3.2 Envigo Business Overview
  16. 8.3.3 Envigo Medical Toxicology Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Envigo Medical Toxicology Service Product Portfolio
  18. 8.3.5 Envigo Recent Developments
  19. 8.4 MPI Research
  20. 8.4.1 MPI Research Company Information
  21. 8.4.2 MPI Research Business Overview
  22. 8.4.3 MPI Research Medical Toxicology Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 MPI Research Medical Toxicology Service Product Portfolio
  24. 8.4.5 MPI Research Recent Developments
  25. 8.5 Eurofins
  26. 8.5.1 Eurofins Company Information
  27. 8.5.2 Eurofins Business Overview
  28. 8.5.3 Eurofins Medical Toxicology Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Eurofins Medical Toxicology Service Product Portfolio
  30. 8.5.5 Eurofins Recent Developments
  31. 8.6 Wuxi Apptec
  32. 8.6.1 Wuxi Apptec Company Information
  33. 8.6.2 Wuxi Apptec Business Overview
  34. 8.6.3 Wuxi Apptec Medical Toxicology Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Wuxi Apptec Medical Toxicology Service Product Portfolio
  36. 8.6.5 Wuxi Apptec Recent Developments
  37. 8.7 SGS
  38. 8.7.1 SGS Company Information
  39. 8.7.2 SGS Business Overview
  40. 8.7.3 SGS Medical Toxicology Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 SGS Medical Toxicology Service Product Portfolio
  42. 8.7.5 SGS Recent Developments
  43. 8.8 Merck
  44. 8.8.1 Merck Company Information
  45. 8.8.2 Merck Business Overview
  46. 8.8.3 Merck Medical Toxicology Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Merck Medical Toxicology Service Product Portfolio
  48. 8.8.5 Merck Recent Developments
  49. 8.9 Evotec
  50. 8.9.1 Evotec Company Information
  51. 8.9.2 Evotec Business Overview
  52. 8.9.3 Evotec Medical Toxicology Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Evotec Medical Toxicology Service Product Portfolio
  54. 8.9.5 Evotec Recent Developments
  55. 8.10 Bureau Veritas
  56. 8.10.1 Bureau Veritas Company Information
  57. 8.10.2 Bureau Veritas Business Overview
  58. 8.10.3 Bureau Veritas Medical Toxicology Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Bureau Veritas Medical Toxicology Service Product Portfolio
  60. 8.10.5 Bureau Veritas Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst